Publication:
Interpretable SMILES-based QSAR model of inhibitory activity of sirtuins 1 and 2

dc.contributor.authorApilak Worachartcheewanen_US
dc.contributor.authorAlla P. Toropovaen_US
dc.contributor.authorAndrey A. Toropoven_US
dc.contributor.authorReny Pratiwien_US
dc.contributor.authorVirapong Prachayasittikulen_US
dc.contributor.authorChanin Nantasenamaten_US
dc.contributor.otherIstituto di Ricerche Farmacologiche Mario Negrien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2022-08-04T08:22:24Z
dc.date.available2022-08-04T08:22:24Z
dc.date.issued2021-09-01en_US
dc.description.abstractBackground: Sirtuin 1 (Sirt1) and sirtuin 2 (Sirt2) are NAD+-dependent histone deacetylases which play important functional roles in the removal of the acetyl group of acetyl-lysine substrates. Considering the dysregulation of Sirt1 and Sirt2 as etiological causes of diseases, Sirt1 and Sirt2 are lucrative target proteins for treatment, thus there has been great interest in the development of Sirt1 and Sirt2 inhibitors. Objective: This study compiled the bioactivity data of Sirt1 and Sirt2 for the construction of quantitative structure-activity relationship (QSAR) models in accordance with the OECD principles. Methods: Simplified molecular-input line-entry system (SMILES)-based molecular descriptors were used to characterize the molecular features of inhibitors while the Monte Carlo method of the CORAL software was employed for multivariate analysis. The dataset was subjected to 3 random splits in which each split separated the data into 4 subsets consisting of training, invisible training, calibration, and external sets. Results: Statistical indices for the evaluation of QSAR models suggested the good statistical quality of models of Sirt1 and Sirt2 inhibitors. Furthermore, mechanistic interpretation of molecular substructures that are responsible for modulating the bioactivity (i.e., promoters of increase or decrease of bioactivity) was extracted via the analysis of correlation weights. It exhibited molecular features involved in Sirt1 and Sirt2 inhibitors. Conclusion: It is anticipated that QSAR models presented herein can be useful as guidelines in the rational design of potential Sirt1 and Sirt2 inhibitors for the treatment of Sirtuin-related diseases.en_US
dc.identifier.citationCombinatorial Chemistry and High Throughput Screening. Vol.24, No.8 (2021), 1217-1228en_US
dc.identifier.doi10.2174/1386207323666200902141907en_US
dc.identifier.issn18755402en_US
dc.identifier.issn13862073en_US
dc.identifier.other2-s2.0-85111420566en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/76593
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111420566&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectComputer Scienceen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleInterpretable SMILES-based QSAR model of inhibitory activity of sirtuins 1 and 2en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111420566&origin=inwarden_US

Files

Collections